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Abstract The Brazilian National Biosafety Com-
mittee approved in 2011 a new post release monitoring
system for environmental releases of genetically
modified organisms. It has a number of novel features
in comparison with other established or proposed
systems. The new system also allows the proponent to
ask for monitoring exemption. General surveillance
forms the basis of the monitoring system, similar to the
European model, but differs markedly in the way it
operates. While the European proposal is based on
monitoring measurable variables extracted from envi-
ronmental observations, from baselines previously
established for multiple protection targets, the Brazil-
ian system uses direct alerts of damage, without the aid
of baseline values. The strength of the Brazilian form
of monitoring is the possibility of generating an
information network with the effective participation of
many actors from the monitored area. A network
constituted by highly qualified members, as proposed
elsewhere, is too complex and unrealistic in Brazil and
in many other countries. In conclusion, the Brazilian
monitoring system is flexible and can be adjusted to
the Brazilian reality over the next years, as a response
to the ever growing experience in monitoring. It also
meets the demands of the Brazilian society for
transparency, rational use of resources, opportunity
for national companies, and food and environmental
biosafety.
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Genetically modified organisms (GMOs) are strictly
regulated in most countries and the risks for the
environment and health are extensively evaluated. To
date, harm attributable to a GMO has not been
substantiated for any commercial release, either to the
environment or to health. Effectively, hundreds of
different GM plants are now in the market and all of
them have been assessed as having negligible risks (see
CERA Database, available at http://www.cera-gmc.
org/?action=gm_crop_database) and as safe as their
non GM counterparts. Nevertheless, long term effects
and other factors are relevant to GMO regulatory
decision-making (Raybould 2012). Consequently, both
Europe (EFSA 2011) and Brazil have adopted moni-
toring as an integral step in risk management. In the
case of Brazil, both public opinion and the requirement
of Article 16 of the Cartagena Protocol on Biosafety to
the Convention on Biological Diversity (Cartagena
Protocol) for post release monitoring (CBD 2000) were
used as the basis of the decision to adopt this strategy.
GMO monitoring is generally regarded as an oppor-
tunity to identify new unanticipated risks derived from
P. P. Andrade (&)  E. A. Kido
Universidade Federal de Pernambuco, Recife, PE, Brazil
e-mail: andrade@ufpe.br
M. A. Melo
Universidade Federal de Campina Grande, Patos, PB,
Brazil
123
Transgenic Res (2014) 23:1043–1047
DOI 10.1007/s11248-014-9787-y
the interaction of a given GMO with a complex
environment over extended areas, by detecting unfore-
seeable harmful effects on the environment and human
health. (FAO 2011; Wilhelm et al. 2003). Moreover, it
can also be used to evaluate performance, what is
usually called product stewardship. On 2011 the Bra-
zilian National Biosafety Committee (CTNBio)
approved a novel system for post release GMO mon-
itoring (available at http://www.ctnbio.gov.br/index.
php/content/view/18000.html). While still following
the general European approach to the question, it differs
in a number of important aspects compared with the
European model and other established or proposed
systems. The Brazilian system adopts general surveil-
lance (GS) as the core process in GMO monitoring,
taken into account that most GMOs have been consid-
ered up to date to be as safe as their non-GM counterpart.
Since all risks have been considered negligible for
approved commercial releases, CTNBio decided that no
case-specific monitoring (CSM) was required. This
approach is similar to those adopted by the European
Union and proposed elsewhere (FAO, op.cit.).
The Brazilian system is novel in does not require
establishment of baselines of measurable variables
extracted from environmental observations as param-
eters for the detection of harm. Instead, it uses actual
damage as an indicator of possible harms derived from
the GMO. This was only possible due to the realization
by CTNBio, based on more than 10 years of intensive
use of GM crops in Brazil and elsewhere, that few
uncertainties remain for consideration by risk manag-
ers. On the other hand, baseline establishment and
follow up were considered to be unrealistic due to
costs and to the specific dynamics of modern agricul-
ture. In addition, there are extensive areas under
cultivation with GM crops of many types. Brazil has
currently more than 40.3 mi hectares of GM crops
(Celeres 2013), and more than 20 events of GM maize,
cotton and soybean (see http://www.ctnbio.gov.br/
index.php/content/view/12492.html).
As in the European proposal, the CTNBio regula-
tion suggests as appropriate the following sources of
information for GS:
I—reports on specific technical meetings held to
assess the technology employed by users;
II—use of accessible and appropriate communica-
tion media or consumer service made available by
the applicant;
III—questionnaires to the technology users and
other actors involved in the process, prepared by the
applicant;
IV—report containing summary and references to
scientific literature published about the GMO event,
or related events in peer reviews, or government
agencies reports;
V—official notification systems; and
VI—other monitoring tools in line with the GMO
use application.
Item III is similar to the farmers questionnaire, a
subject of great interest in Europe and with which
EFSA was involved since 2007, to help define the
parameters for GS (Waigmann et al. 2012). The other
parameters are broadly equivalent to those proposed
by different sources.
Flowchart in Fig. 1 summarizes the steps leading to
the adoption of a monitoring plan for a given GMO
coming to the market or to its exemption, as well as the
various decisions and actions within the plan.
The Brazilian post release monitoring system also
allows in certain cases exemption from monitoring.
There are already some cases in which exemption
could be justified, for example, GMOs that are not
released alive into the environment (e.g., microorgan-
isms grown in fermentation tanks), or for those that do
not proliferate in the environment (such as transgenic
mosquitoes that die after a few days and whose progeny
also die). A recent case of exemption relates to a GM
yeast that was withdrawn from the market. This will
certainly be the case of many GM plant events that will
be substituted by more modern varieties, having single
or stacked events. Over time, other cases of exemption
will have to be considered by CTNBio. Nevertheless, a
transgenic mosquito is currently been evaluated by
CTNBio and its proponent also decided to develop a
monitoring plan, although exemption may have been
considered.
It is important to keep in mind that the Brazilian law
does not require GMO post release monitoring. Both
the Brazilian and the international experience on the
cultivation and use of various GMOs continue to build
and will certainly lay down a solid foundation of risk
management. This will determine whether it is pro-
ductive to monitor a new GM, or if the information
available will allow the exemption of this procedure.
The exemption option is thus a useful feature as it is
aligned with the best science, fits the previous risk
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assessment and avoids the expenditure of time,
resources and personnel on monitoring products with
a history of safe use, or which cannot be monitored by
technical issues. Mandatory monitoring may add to the
regulatory burden without providing additional pro-
tection to humans, livestock or the environment.
Case-specific monitoring may be triggered by the
occurrence of damage with a proven link to the GMO.
According to the Brazilian proposal, early damage
warnings generated by the monitoring network must be
first assessed by the company (which conducts
monitoring and pays its cost) and a technical report
must then be submitted to CTNBio for each alert. If a
scientific plausible link between the damage and the
monitored GMO is found, laboratory experiments are
conducted to test the hypothesis (with oversight by
CTNBio). If there is corroboration of causality, mitiga-
tion measures should be adopted and the CSM is
therefore triggered. Alternatively, CSM can be triggered
from the very start of the monitoring plan if non-
negligible risks are identified in the risk assessment prior
to commercial release. The pertinent decisions and
Fig. 1 Actions and decision steps in the approval and
implementation of a post release monitoring plan, or to its
exemption, as in the Brazilian CTNBio Regulation #9. The
monitoring plan must be submitted to CTNBio only when the
risk assessment has been completed and the authorization of
commercial release has been granted. If the exemption is
granted, the process ends. Otherwise, the monitoring plan
usually starts as a GS and will continue until the deadline is
reached, unless damages associated with GMOs are observed
during the period; in this case a CSM plan is enabled. Other
decision steps and actions are depicted in the figure
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actions underlying GS and CSM are summarized in
Fig. 2 below (part of the flowchart in Fig. 1).
Deadlines are also an important cause of concern.
For example, monitoring of a yeast grown in industrial
tanks may need to be no greater than 2 years. Maize,
soybean and other annual crops could be monitored for
5 years, but since farmers usually rotate crops and
change events, it is generally difficult to monitor the
same area for a large period. To establish deadlines for
perennial trees is a real challenge, as well as for sugar
cane. Another controversial issue is the substitution of
single events by their higher order stacked product in
monitoring plans, a strategy allowed in the Normative.
CTNBio hopes that a fresh flow of information derived
from the monitoring plans now under its supervision
will shed more light on these issues.
In conclusion, the strength of the Brazilian monitor-
ing system is the possibility of generating an informa-
tion network with the effective participation of many
stakeholders from the monitored areas. Although the
European proposal also describes a network, it is much
more restricted because it is responsible for creating
baselines and is strongly dependent on high qualification
of its members. To build such a network is complex and
unrealistic in Brazil and in many other countries,
especially among government agencies responsible for
technical training on agricultural practices, seed sellers,
producers’ associations and other forms of social
Fig. 2 Excerpt taken from the general flow chart showing how
a damage alert (real adverse effect) generated during GS can
trigger experiments and ultimately CSM. An alert requires the
finding of an adverse effect (damage); if it is substantiated, the
alert generates a technical report that CTNBio, together with the
company, must analyse to find an eventual causation link
between the GMO and the harm. If there is scientific basis for
causation, specific experiments should be performed, whose
results will determine the subsequent actions
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organization. The quality of the network will be
evaluated by the consistency of the alerts. On the other
hand, the network is not open to the public, as it has to be
approved by CTNBio. Thus, a well-built network
represents an invaluable source of information, without
the need to establish expensive baselines and with
minimizing the number of false damage reports. The
Brazilian post-release monitoring system seems there-
fore able to be implemented as a rigorous, thorough and
effective protocol, in spite of only triggering significant
action if case of substantiated damage. It is important to
keep in mind that possible damages will be restricted to
the areas where the specific event under monitoring was
adopted in large scale and that no such damages where
ever reported for previous commercially released
GMOs.
Irrespective of how complex the post release
monitoring could be, it will always be limited in its
ability to cover all possible unanticipated risks. Above
all, it will not be able to eliminate all uncertainty
(Sanvido et al. 2011), but which are presently mini-
mal. Therefore, it is expected that exemption will be
increasingly asked for by proponents of new products,
except for stewardship (which can also signal unan-
ticipated risks).
The new monitoring system will have costs cer-
tainly compatible with its possible results. It is also
flexible and can be adjusted to the Brazilian reality over
the next years, as a response to the ever growing
Brazilian and international experience in monitoring. It
also meets the demands of the Brazilian society for
transparency, rational use of resources, opportunity for
national companies and food and environmental bio-
safety, and without using an excessive regulatory
burden.
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